All articles tagged: Myeloid leukemia, unspecified, not having achieved remission (C92.90)


HealthDay 24 June at 02.59 PM Posttransplant Cyclophosphamide GVHD Prophylaxis Beneficial in Leukemia For patients with acute myeloid leukemia (AML) undergoing allogeneic stem cell transplantation, posttransplant cyclophosphamide (PTCy) graft-versus-host-disease (GVHD) prophylaxis yields comparable relapse incidence (RI) and significantly lower incidence of GVHD than conventional prophylaxis, according to a study published online June 10 in the Ame # Hematology & Oncology 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
HealthDay 18 January at 11.04 PM Risk for Cancer Increased for Relatives of Patients With Leukemia Relatives of patients with myelodysplastic neoplasia (MDS), acute myeloid leukemia (AML), or acute lymphoblastic leukemia (ALL) have an increased risk for cancer, according to a study published in the February issue of Cancer Epidemiology.Nikolaj Juul Nitschke, from Copenhagen University Hospital in Denmark, and colleagues estimated t # Internal Medicine # Family Practice # Hematology & Oncology 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
HealthDay 21 December at 04.47 PM American Society of Hematology, Dec. 9 to 12 The annual meeting of the American Society of Hematology was held from Dec. 9 to 12 in San Diego and attracted participants from around the world, including hematology specialists as well as clinical practitioners and other health care professionals. The conference featured presentations focusing on the diagnosis, treatment, and # Hematology & Oncology 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
HealthDay 21 December at 04.30 PM Allogeneic HCT After Primary Induction Failure Beneficial in Leukemia For patients with acute myeloid leukemia (AML), immediate allogeneic hematopoietic stem cell transplantation (HCT) after primary induction failure (PIF) offers long-term survival benefit, according to a study published online Dec. 10 in the Blood Cancer Journal.Miriam Mozaffari Jovein, M.D., from the University of Freiburg in Germany, # Hematology & Oncology 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
HealthDay 20 December at 04.53 PM Peripheral Blood Haplo-SCT Feasible for Leukemia Patients 70 Years and Older For patients with acute myeloid leukemia (AML)/myelodysplastic syndromes (MDS) aged 70 years and older, haploidentical stem cell transplantation (Haplo-SCT) using a nonmyeloablative conditioning regimen (NMAC) is feasible, with no early nonrelapse mortality (NRM), according to a study published online Nov. 3 in Bone Marrow Transplantation.< # Hematology & Oncology 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
HealthDay 19 December at 04.59 AM Air Pollution May Increase Risk for Childhood Leukemia Exposure to traffic-related air pollution may be associated with an increased risk for childhood leukemia, according to a study published in the August issue of Environment International.Christian Kreis, Ph.D., from the University of Bern in Switzerland, and colleagues investigated the association between traffic-related air pollution # Pediatrics # Hematology & Oncology 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn

HealthDay 13 December at 03.33 PM Increasing Body Mass Index Tied to 18 Site-Specific Cancers in Men Increasing body mass index (BMI) at age 18 years is associated with development of subsequent site-specific cancers in men, according to a study published online Nov. 6 in Obesity.Aron Onerup, M.D., Ph.D., from the University of Gothenburg in Sweden, and colleagues examined BMI at age 18 years and incident site-specific cancer ( # Pediatrics # Gastroenterology # Internal Medicine # Urology 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn


HealthDay 22 November at 04.44 PM Semaglutide, Liraglutide May Reduce Hospitalization Risk for Alcohol Use Disorder Semaglutide and liraglutide are associated with a reduced risk for hospitalization due to alcohol use disorder (AUD), according to a study published online Nov. 13 in JAMA Psychiatry.Markku Lähteenvuo, M.D., Ph.D., from the University of Eastern Finland in Kuopio, and colleagues conducted an observational study in Sweden using data from 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medpage Today 17 November at 10.31 PM Two Treatments That Don't Work for Osteoarthritis WASHINGTON -- If you're looking for nonsurgical osteoarthritis (OA) treatments with fewer side effects than ordinary pain relievers, two randomized trials presented here with negative results should at least narrow your search... 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
MedScape 11 November at 07.56 AM Scoring System Could Mean Better Access to Lung Transplant Scoring system could improve access for hard-to-match candidates due to height and blood type. 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medical xPress 07 November at 07.50 AM How key results could influence health policy The results of some congressional races may foreshadow who will have outsize health policy influence in Congress next year. 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medpage Today 05 November at 07.00 PM Mpox Cases in Congo May Be Stabilizing GOMA, Congo -- Some health officials say mpox cases in Congo appear to be "stabilizing" -- a possible sign that the main epidemic for which the World Health Organization (WHO) made a global emergency declaration in August... 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medical xPress 02 November at 07.40 AM Insulin resistance caused by sympathetic nervous system over-activation, a paradigm-shifting study finds Rutgers Robert Wood Johnson Medical School and collaborating institutions have found that overnutrition leads to insulin resistance and metabolic disorders through increased activity of the sympathetic nervous system (SNS). The study shows that reducing SNS activity can prevent insulin resistance induced by a high-fat diet, suggesting a new understanding of how obesity causes insulin resistance. 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn

MedScape 31 October at 06.30 AM Report: Rethink Race-Based Adjustments in Clinical Tools The slow adoption of race-neutral tools may harm patient care outcomes, according to a new report from the National Academies of Sciences, Engineering, and Medicine. 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medpage Today 25 October at 02.09 PM Patients More Satisfied With AI's Answers Than Those From Their Doctor Patients were consistently more satisfied with responses from artificial intelligence (AI) to messages in the electronic health record than they were with those from their clinician, according to a study in JAMA Network Open... 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medical xPress 25 October at 12.40 PM Surgical innovation: The intelligent turbine insufflator The Politecnico di Milano and the Erasmus Medical Center in Rotterdam have pooled their medical and technical expertise to create a new technology for devices called "insufflators." These innovative instruments are designed to create a temporary cavity in the bodies of patients through the application of pressurized gas, providing the surgeon with the necessary space to perform the surgical proced 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medical xPress 24 October at 07.50 AM Genetic variants in melatonin receptor linked to idiopathic osteoporosis Columbia University Medical Center researchers have identified specific variants in a melatonin receptor gene that impair bone turnover, leading to significant reductions in bone density and increased risk of fractures, particularly in Ashkenazi Jewish individuals. 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn